The first P.E.I medical marijuana facility is under construction. Called Canada’s Island Garden, the 24,000-square-foot facility, which will contain two floors for growing cannabis and a 3,600-square-foot office, is slated for completion in November. It is in BioCommons Research Park — a business park which caters to the bioscience industry.
Health Canada has granted Hydropothecary, CanniMed, and Tilray medical marijuana oil production licences. On July 8, 2015 the Government of Canada announced it would allow licensed producers of medical marijuana to produce and sell medical marijuana oil under new supplementary licences. This was in direct response to the June 11,
Health Minister Rona Ambrose has ordered a crackdown on groups that illegally advertise marijuana, and has reiterated the Conservative party’s pledge to keep storefront dispensaries illegal in an press release issued on Saturday. “The law is quite clear that dispensaries, whether they are online or a store-front, are illegal and
The Federal Court of Canada has certified a class-action lawsuit involving over 40,000 people in the medical marijuana access program. Justice Michael Phelan heard the certification application in Federal Court in Halifax in June. On July 27, 2015, the Federal Court of Canada released its order and reasons granting the
Stratford, Ontario city council will consider an agreement of purchase and sale on July 27th 2015 with GreenSeal Cannabis Company Ltd. for two parcels of industrial land totaling 1.7 acres in the city’s Wright Business Park, with an option in the agreement for another 0.7 acres in the future. The
By Paula McCooney This article originally appeared on Ottawa Citizen, April 23rd 2015. A former Health Canada manager who helped Canadians navigate the sometimes hazy world of medical marijuana access has been appointed CEO of an emerging company that educates patients on its use. Gulwant Bajwa, 53, has taken on
This article has been re-posted from the May – June 2005 Cannabis Health Journal. The following interview was conducted by Cannabis Health with Dr. Richard Viau, Acting Director General of Health Canada’s Drug Strategy and Controlled Substances Programme. In preparation for the interview, we polled various members of the global